Mucopolysaccharidosis type 1

Mucopolysaccharidosis type I (MPS I) is an inherited lysosomal disorder caused by pathogenic variants in the IDUA gene. It is transmitted in an autosomal recessive pattern and is due to the deficiency of the enzyme alpha-L-iduronidase, which is necessary for the degradation of the glycosaminoglycans dermatan sulfate and heparan sulfate. Its progressive accumulation in lysosomes causes multisystem involvement, especially skeletal, cardiac, respiratory, ocular, and neurological.

The IDUA gene encodes the enzyme alpha-L-iduronidase, a lysosomal hydrolase responsible for removing alpha-L-iduronic acid residues during the degradation of glycosaminoglycans (GAGs), primarily dermatan sulfate and heparan sulfate. These compounds are part of the extracellular matrix and must be continuously recycled. When IDUA activity is reduced or absent, GAGs are not degraded properly and accumulate within lysosomes, altering cell function and the normal development of multiple tissues.

MPS I constitutes a continuous clinical spectrum that has traditionally been divided into Hurler, Hurler-Scheie, and Scheie syndromes, although it is currently usually classified into severe and attenuated forms. Severe forms present with progressive neurological involvement, while attenuated forms usually preserve cognitive function but can present with significant osteoarticular, cardiac, respiratory, and ocular disease. The disease is inherited in an autosomal recessive manner; affected individuals inherit two pathogenic variants in IDUA, one from each parent. Its global incidence is estimated at around 1 in 100,000 live births, with variations between populations.

Symptoms

The age of onset and severity depend on the phenotype. The severe form usually manifests during the first year of life with coarse facial features, recurrent respiratory infections, hernias, hepatosplenomegaly, multiple dysostoses, joint stiffness, corneal clouding, and developmental delay. With progression, hydrocephalus, hearing loss, valvular heart disease, and neurological deterioration may appear. Milder forms usually begin later, in childhood or adolescence, with joint involvement, short stature, respiratory problems, corneal clouding, and heart disease, generally without significant cognitive impairment.

Disease management

Management requires multidisciplinary follow-up and specific treatment when indicated. Enzyme replacement therapy with intravenous laronidase may improve somatic manifestations such as hepatosplenomegaly, exercise intolerance, and respiratory function, although its central nervous system penetration is limited. In the severe form, early hematopoietic stem cell transplantation is the treatment of choice to attempt to preserve neurological function and improve survival. In addition, cardiological, respiratory, ophthalmological, auditory, and orthopedic monitoring is necessary, as well as management of infections, sleep apnea, pain, and functional limitation.

Genes analyzed

IDUA U
U Ultra Whole Genome Sequencing 30x

Bibliography

Clarke LA. Mucopolysaccharidosis Type I. 2002 Oct 31 [updated 2025 Dec 4]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.

Poletto E, Pasqualim G, Giugliani R, et al. Worldwide distribution of common IDUA pathogenic variants. Clin Genet. 2018 Jul;94(1):95-102.

Gul R, Firasat S, Hussain M, et al. IDUA gene mutations in mucopolysaccharidosis type-1 patients from two Pakistani inbred families. Congenit Anom (Kyoto). 2020 Jul;60(4):126-127.

Zahoor MY, Cheema HA, Ijaz S, et al. Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1. J Pediatr Endocrinol Metab. 2019 Nov 26;32(11):1221-1227.

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy